FI970247L - Farmaseuttisia koostumuksia, jotka sisältävät kimeerisen TNF:ää sitovan proteiinin - Google Patents

Farmaseuttisia koostumuksia, jotka sisältävät kimeerisen TNF:ää sitovan proteiinin Download PDF

Info

Publication number
FI970247L
FI970247L FI970247A FI970247A FI970247L FI 970247 L FI970247 L FI 970247L FI 970247 A FI970247 A FI 970247A FI 970247 A FI970247 A FI 970247A FI 970247 L FI970247 L FI 970247L
Authority
FI
Finland
Prior art keywords
pharmaceutical compositions
binding protein
compositions containing
chimeric tnf
tnf
Prior art date
Application number
FI970247A
Other languages
English (en)
Swedish (sv)
Other versions
FI970247A0 (fi
FI970247A7 (fi
Inventor
Robert Fredrich Geoffrey Booth
Werner Lesslauer
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of FI970247A0 publication Critical patent/FI970247A0/fi
Publication of FI970247A7 publication Critical patent/FI970247A7/fi
Publication of FI970247L publication Critical patent/FI970247L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI970247A 1994-07-22 1995-07-15 Farmaseuttisia koostumuksia, jotka sisältävät kimeerisen TNF:ää sitovan proteiinin FI970247L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94111455 1994-07-22
PCT/EP1995/002788 WO1996003141A1 (en) 1994-07-22 1995-07-15 Pharmaceutical compositions comprising a chimaeric tnf binding protein

Publications (3)

Publication Number Publication Date
FI970247A0 FI970247A0 (fi) 1997-01-21
FI970247A7 FI970247A7 (fi) 1997-01-21
FI970247L true FI970247L (fi) 1997-01-21

Family

ID=8216138

Family Applications (1)

Application Number Title Priority Date Filing Date
FI970247A FI970247L (fi) 1994-07-22 1995-07-15 Farmaseuttisia koostumuksia, jotka sisältävät kimeerisen TNF:ää sitovan proteiinin

Country Status (11)

Country Link
EP (1) EP0772449A1 (fi)
JP (1) JPH09508140A (fi)
AU (1) AU3111995A (fi)
BR (1) BR9508419A (fi)
CA (1) CA2195665A1 (fi)
CZ (1) CZ283219B6 (fi)
FI (1) FI970247L (fi)
HU (1) HUT76666A (fi)
NO (1) NO970264L (fi)
PL (1) PL318501A1 (fi)
WO (1) WO1996003141A1 (fi)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6471956B1 (en) 1994-08-17 2002-10-29 The Rockefeller University Ob polypeptides, modified forms and compositions thereto
US6001968A (en) 1994-08-17 1999-12-14 The Rockefeller University OB polypeptides, modified forms and compositions
US6350730B1 (en) 1994-08-17 2002-02-26 The Rockefeller University OB polypeptides and modified forms as modulators of body weight
US6429290B1 (en) 1994-08-17 2002-08-06 The Rockefeller University OB polypeptides, modified forms and derivatives
US6936439B2 (en) 1995-11-22 2005-08-30 Amgen Inc. OB fusion protein compositions and methods
US20030040467A1 (en) 1998-06-15 2003-02-27 Mary Ann Pelleymounter Ig/ob fusions and uses thereof.
TR199802238T2 (xx) * 1996-05-08 1999-02-22 F. Hoffmann-La Roche Ag Astımın TNFR-Ig ile tedavisi.
TW555765B (en) * 1996-07-09 2003-10-01 Amgen Inc Low molecular weight soluble tumor necrosis factor type-I and type-II proteins
US7070771B1 (en) 1996-12-09 2006-07-04 Regents Of The University Of California Methods of expressing chimeric mouse and human CD40 ligand in human CD40+ cells
EP0948543A1 (en) * 1996-12-12 1999-10-13 Genentech, Inc. Hvem polypeptides and uses thereof
AU769964B2 (en) 1998-11-27 2004-02-12 Synaptics (Uk) Limited Position sensor
KR20040052481A (ko) 2001-02-23 2004-06-23 임뮤넥스 코포레이션 재조합 단백질의 수득률을 증가시키는 방법
WO2003011323A1 (en) * 2001-07-30 2003-02-13 Genset S.A. Agonists and antagonists of contabix for use in the treatment of metabolic disorders
US7786282B2 (en) 2001-12-06 2010-08-31 The Regents Of The University Of California Nucleic acid molecules encoding TNF-α ligand polypeptides having a CD154 domain
AU2003209755B2 (en) 2002-02-06 2007-11-22 Ares Trading S.A. Tumor necrosis factor combined with interferon in demyelinating diseases
AU2005299716B2 (en) 2004-10-22 2012-09-06 Amgen Inc. Methods for refolding of recombinant antibodies
CA2958578A1 (en) 2014-08-21 2016-02-25 The General Hospital Corporation Tumor necrosis factor superfamily and tnf-like ligand muteins and methods of preparing and using the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL98078A0 (en) * 1991-05-07 1992-06-21 Yeda Res & Dev Pharmaceutical compositions comprising an anticytokyne
EP1132471A3 (de) * 1989-09-12 2001-11-28 F. Hoffmann-La Roche Ag TNF-bindende Proteine
GB9015908D0 (en) * 1990-07-19 1990-09-05 Celltech Ltd Multivalent immunoglobulin
WO1994006476A1 (en) * 1992-09-15 1994-03-31 Immunex Corporation Method of treating tnf-dependent inflammation using tumor necrosis factor antagonists
EP0671936A1 (en) * 1992-10-15 1995-09-20 Dana-Farber Cancer Institute, Inc. TREATMENT OF INSULIN RESISTANCE IN OBESITY LINKED TYPE II DIABETES USING ANTAGONISTS TO TNF-$g(a) FUNCTION

Also Published As

Publication number Publication date
PL318501A1 (en) 1997-06-23
FI970247A0 (fi) 1997-01-21
EP0772449A1 (en) 1997-05-14
BR9508419A (pt) 1997-11-18
CZ19397A3 (en) 1997-06-11
HUT76666A (en) 1997-10-28
FI970247A7 (fi) 1997-01-21
WO1996003141A1 (en) 1996-02-08
NO970264L (no) 1997-03-24
CZ283219B6 (cs) 1998-02-18
NO970264D0 (no) 1997-01-21
AU3111995A (en) 1996-02-22
JPH09508140A (ja) 1997-08-19
CA2195665A1 (en) 1996-02-08

Similar Documents

Publication Publication Date Title
FI20071025L (fi) Farmaseuttisia koostumuksia
CY2005007I2 (el) Φαρμακευτικες συνθεσεις που περιεχουν δαριφενακινη
FI965202A0 (fi) Farmaseuttiset takriinikoostumukset
NO962606L (no) Farmasöytisk sammensetning
FI970247L (fi) Farmaseuttisia koostumuksia, jotka sisältävät kimeerisen TNF:ää sitovan proteiinin
IS1903B (is) 2-methýl-thíenó-bensódíasepín, samsetning til inntöku
FI964682L (fi) Glukagonia sisältävä farmaseuttinen valmiste
IS4706A (is) Lyfjasamsetningar
DE69508180D1 (de) Heissschmelzende Tintenstrahlzusammensetzung
KR970703779A (ko) 건강 조성물(health composition)
FI972434L (fi) Lamotrigiiniä sisältävä farmaseuttinen koostumus
FI973586L (fi) Tahnamainen puhdistuskoostumus
BR9507768A (pt) Composição farmacêutica
EE9800400A (et) Diklofenaaki sisaldavad farmatseutilised kompositsioonid
FI973229A7 (fi) Uusi farmaseuttinen koostumus
ITMI942166A0 (it) Composizioni farmaceutiche miorilassanti
FI973280A7 (fi) Farmaseuttinen koostumus
ITMI950961A0 (it) Composizioni farmaceutiche contenenti gemfibrozil
FI952377A0 (fi) Farmaseuttisia ibuprofeenikoostumuksia
FI962979A7 (fi) Hirudiinia sisältävät farmaseuttiset koostumukset
FI962738A0 (fi) Farmaseuttiset koostumukset
FI954050L (fi) Lääkekoostumuksia
NO964309D0 (no) Farmasöytisk sammensetning
IT1272935B (it) Composizione farmaceutica contenente n-acetil-cisteina
IT1285093B1 (it) Composizione farmaceutica per malattie cardiovascolari e renali.